Regulation of vascular smooth muscle tone by adipose-derived contracting factor

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Meyer, Matthias R ^a,c   Fredette, Natalie C ^a   Barton, Matthias ^b   Prossnitz, Eric R ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE DERIVED CONTRACTING FACTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIN RECEPTOR; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; PROSTAGLANDIN SYNTHASE; SEROTONIN; SUPEROXIDE; THROMBOXANE A2; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; OBESITY; PERIVASCULAR ADIPOSE; SMOOTH MUSCLE TONE; VASCULAR SMOOTH MUSCLE;

ADIPOSE TISSUE; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HYPERTENSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OBESITY; THROMBOXANE A2; VASODILATION;

EID: 84892963105     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079245     Document Type: Article

References (69)

1. Ouwens DM, Sell H, Greulich S, Eckel J (2010) The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med 14: 2223-2234.
2. Maenhaut N, Van de Voorde J (2011) Regulation of vascular tone by adipocytes. BMC Med 9: 25.
3. Gollasch M (2012) Vasodilator signals from perivascular adipose tissue. Br J Pharmacol 165: 633-642.
4. Eringa EC, Bakker W, van Hinsbergh VW (2012) Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vascul Pharmacol 56: 204-209.
5. Gao YJ, Takemori K, Su LY, An WS, Lu C, et al. (2006) Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 71: 363-373.
6. Soltis EE, Cassis LA (1991) Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 13: 277-296.
7. Löhn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, et al. (2002) Periadventitial fat releases a vascular relaxing factor. FASEB J 16: 1057-1063.
8. Fésüs G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, et al. (2007) Adiponectin is a novel humoral vasodilator. Cardiovasc Res 75: 719-727.
9. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, et al. (2009) Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119: 1661-1670.
10. Ma L, Ma S, He H, Yang D, Chen X, et al. (2010) Perivascular fat-mediated vascular dysfunction and remodeling through the AMPK/mTOR pathway in high-fat diet-induced obese rats. Hypertens Res 33: 446-453.
11. Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, et al. (2010) Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 210: 656-661.
12. Traupe T, Lang M, Goettsch W, Münter K, Morawietz H, et al. (2002) Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 20: 2239-2245.
13. Traupe T, d'Uscio LV, Muenter K, Morawietz H, Vetter W, et al. (2002) Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin. Clin Sci (Lond) 103 Suppl 48: 13S-15S.
14. Meyer MR, Amann K, Field AS, Hu C, Hathaway HJ, et al. (2012) Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension 59: 507-512.
15. Furchgott RF, Vanhoutte PM (1989) Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018.
16. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
17. Prossnitz ER, Barton M (2011) The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 7: 715-726.
18. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, et al. (2009) Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 104: 288-291.
19. Ford J, Hajibeigi A, Long M, Hahner L, Gore C, et al. (2011) GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice. J Bone Miner Res 26: 298-307.
20. Wang C, Dehghani B, Li Y, Kaler LJ, Proctor T, et al. (2009) Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J Immunol 182: 3294-3303.
21. Barton M, Carmona R, Morawietz H, d'Uscio LV, Goettsch W, et al. (2000) Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension 35: 329-336.
22. Barton M, Baretella O, Meyer MR (2012) Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol 165: 591-602.
23. Cardillo C, Campia U, Iantorno M, Panza JA (2004) Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension 43: 36-40.
24. Ghiadoni L, Penno G, Giannarelli C, Plantinga Y, Bernardini M, et al. (2008) Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension 51: 440-445.
25. Campia U, Tesauro M, Cardillo C (2012) Human obesity and endothelium-dependent responsiveness. Br J Pharmacol 165: 561-573.
26. Farb MG, Tiwari S, Karki S, Ngo DT, Carmine B, et al. (2013) Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. Obesity (Silver Spring): (in press); doi: 10.1002/oby.20505.
27. Sharma G, Hu C, Brigman JL, Zhu G, Hathaway HJ, et al. (2013) GPER deficiency in male mice results in insulin resistance, dyslipidemia and a proinflammatory state. Endocrinology August 22 (epub ahead of print) doi:10.1210/en.2013-1357.
28. Meyer MR, Field AS, Kanagy NL, Barton M, Prossnitz ER (2012) GPER regulates endothelin-dependent vascular tone and intracellular calcium. Life Sci 91: 623-627.
29. West DB, Boozer CN, Moody DL, Atkinson RL (1992) Dietary obesity in nine inbred mouse strains. Am J Physiol 262: R1025-1032.
30. Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L, et al. (2008) Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens 21: 1288-1291.
31. Mulvany MJ, Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26.
32. Baretella O, Xu A, Vanhoutte PM (2013) Acidosis prevents and alkalosis augments endothelium-dependent contractions in mouse arteries. Pflugers Arch July 20 (epub ahead of print) doi: 10.1007/s00424-00013-01323-z.
33. Ihara M, Ishikawa K, Fukuroda T, Saeki T, Funabashi K, et al. (1992) In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol 20 Suppl 12: S11-S14.
34. Ospina JA, Duckles SP, Krause DN (2003) 17beta-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am J Physiol Heart Circ Physiol 285: H241-H250.
35. Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A 72: 2994-2998.
36. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
37. DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235: E97-E102.
38. Chiou WL (1978) Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level - time curve. J Pharmacokinet Biopharm 6: 539-546.
39. Fitzgibbons TP, Kogan S, Aouadi M, Hendricks GM, Straubhaar J, et al. (2011) Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am J Physiol Heart Circ Physiol 301: H1425-H1437.
40. Ketonen J, Shi J, Martonen E, Mervaala E (2010) Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 74: 1479-1487.
41. Xu L, Miyoshi H, Nishimura K, Jisaka M, Nagaya T, et al. (2007) Gene expression of isoformic enzymes in arachidonate cyclooxygenase pathway and the regulation by tumor necrosis factor alpha during life cycle of adipocytes. Prostaglandins Other Lipid Mediat 83: 213-218.
42. Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387-437.
43. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
44. Rubanyi GM, Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250: H822-827.
45. Li H, Forstermann U (2013) Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease. Curr Opin Pharmacol 13: 161-167.
46. Wilcox CS, Pearlman A (2008) Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev 60: 418-469.
47. Feletou M, Vanhoutte PM (2006) Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 291: H985-H1002.
48. Aghamohammadzadeh R, Heagerty AM (2012) Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue. Ann Med 44 Suppl 1: S74-S84.
49. Kellaway CH, Trethewie ER (1940) The liberation of a slow-reacting smooth muscle-stimulating substance in anaphylaxis. Quart J Exp Physiol 30: 121-145.
50. Campbell DH, Nicoll PA (1940) Studies on in vitro anaphylaxis and release of an active non-histamine material from sensitized guinea pig lung. J Immunol 39: 103-112.
51. Berry PA, Collier HO (1964) Bronchoconstrictor action and antagonism of a slow-reacting substance from anaphylaxis of guinea-pig isolated lung. Br J Pharmacol Chemother 23: 201-216.
52. Ferreira SH, Vargaftig BB (1974) Inhibition by non-steroid anti-inflammatory agents of rabbit aorta contracting activity generated in blood by slow reacting substance C. Br J Pharmacol 50: 543-551.
53. Gryglewski R, Vane JR (1972) The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti-inflammatory drugs. Br J Pharmacol 45: 37-47.
54. Piper PJ, Vane JR (1969) Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 223: 29-35.
55. Gryglewski R, Vane JR (1972) The generation from arachidonic acid of rabbit aorta contracting substance (RCS) by a microsomal enzyme preparation which also generates prostaglandins. Br J Pharmacol 46: 449-457.
56. Nijkamp FP, Flower RJ, Moncada S, Vane JR (1976) Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids. Nature 263: 479-482.
57. De Mey JG, Vanhoutte PM (1982) Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res 51: 439-447.
58. Smith AD, Dorrance AM (2006) Arachidonic acid induces augmented vasoconstriction via cyclooxygenase 1 in the aorta from rats fed a high-fat diet. Prostaglandins Leukot Essent Fatty Acids 75: 43-49.
59. Goodwill AG, James ME, Frisbee JC (2008) Increased vascular thromboxane generation impairs dilation of skeletal muscle arterioles of obese Zucker rats with reduced oxygen tension. Am J Physiol Heart Circ Physiol 295: H1522-H1528.
60. Tang EH, Ku DD, Tipoe GL, Feletou M, Man RY, et al. (2005) Endothelium-dependent contractions occur in the aorta of wild-type and COX2-/- knockout but not COX1-/- knockout mice. J Cardiovasc Pharmacol 46: 761-765.
61. Xu J, Xiang Q, Lin G, Fu X, Zhou K, et al. (2012) Estrogen improved metabolic syndrome through down-regulation of VEGF and HIF-1alpha to inhibit hypoxia of periaortic and intra-abdominal fat in ovariectomized female rats. Mol Biol Rep 39: 8177-8185.
62. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, et al. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56: 901-911.
63. Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, et al. (1998) Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 102: 1994-2001.
64. Chang L, Milton H, Eitzman DT, Chen YE (2013) Paradoxical roles of perivascular adipose tissue in atherosclerosis and hypertension. Circ J 77: 11-18.
65. Chang L, Villacorta L, Li R, Hamblin M, Xu W, et al. (2012) Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-gamma deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 126: 1067-1078.
66. Barton M (2013) Prevention and endothelial therapy of coronary artery disease. Curr Opin Pharmacol 13: 226-241.
67. Bailey JM, Makheja AN, Butler J, Salata K (1979) Anti-inflammatory drugs in experimental atherosclerosis. Part 4. Inhibition of atherosclerosis in vivo and thromboxane synthesis and platelet aggregation in vitro. Atherosclerosis 32: 195-203.
68. Pratico D, Tillmann C, Zhang ZB, Li H, FitzGerald GA (2001) Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci U S A 98: 3358-3363.
69. Ohman MK, Luo W, Wang H, Guo C, Abdallah W, et al. (2011) Perivascular visceral adipose tissue induces atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis 219: 33-39.